Reporting owner · CIK 0001816210

Patel Sanjiv

Visual SEC Form 4 history across 1 companies, 10 transactions and 5 filings.

PRESPresident and CEORelay Therapeutics, Inc.
Open-market mix
Latest filingAug 18, 2026, 08:17 PM
Filings5Form 4 records
Buying$00 purchases
Selling$3.9M7 sales
Net value−$3.9MBuys minus sells
Companies12 securities
Most recentAug 17, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-53Jan 252Feb 25Dec 251Jan 261Aug 26

Net value flow

Buys minus sells

Jan 25
−$1.8M
Feb 25
−$818.4K
Dec 25
$0
Jan 26
−$337.6K
Aug 26
−$979.9K

Transaction texture

Ownership and ticket size

Average P/S size$556.9K
Median P/S size$565K
Direct7
Indirect3
Aug 17, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern2Delayed Filingfiling-context1Derivative Transactionfiling-context1Direct Ownershipfiling-context7Large Holdings Increaseholdings2Large Holdings Reductionholdings3Repeat Sellerpattern410b5-1 Detectedfiling-context4

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Relay Therapeutics, Inc. on Aug 17, 2026 valued at $979,886.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Relay Therapeutics, Inc. on Aug 17, 2026 valued at $979,886.

Review SEC filing

Associated companies

Visual map of known reporting history

RLAYRelay Therapeutics, Inc.10 transactions · latest Aug 18, 2026, 08:17 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
RLAYPatel Sanjiv
PRES
sale10b5-148.1k-$97.9MS
Cluster Selling Direct Ownership 10b5-1 Detected
−10.3%08/1808/17
RLAYPatel Sanjiv
PRES
sale43.1k-$33.7MS
Direct Ownership
—01/0701/06
RLAYPatel Sanjiv
PRES
grant994$297kA
Delayed Filing Direct Ownership
—01/0712/31/2025
RLAYPatel Sanjiv
PRES
sale75.3k-$27.8MS
Direct Ownership Repeat Seller
—02/14/202502/13/2025
RLAYPatel Sanjiv
PRES
grant332k$0A
Direct Ownership Large Holdings Increase
—02/14/202502/11/2025
RLAYPatel Sanjiv
PRES
sale140k-$53.9MS
Cluster Selling Direct Ownership Repeat Seller
—02/14/202502/11/2025
RLAYPatel Sanjiv
PRES
sale10b5-1125k-$59.7MS
Large Holdings Reduction Repeat Seller 10b5-1 Detected
—01/24/202501/23/2025
RLAYPatel Sanjiv
PRES
sale10b5-1125k-$60.0MS
Large Holdings Reduction Repeat Seller 10b5-1 Detected
—01/24/202501/22/2025
RLAYPatel Sanjiv
PRES
sale10b5-1125k-$56.5MS
Large Holdings Reduction 10b5-1 Detected
—01/24/202501/21/2025
RLAYPatel Sanjiv
PRES
grant1.10M$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—01/15/202501/10/2025

Patel Sanjiv Insider Activity FAQ

SEC Form 4 context

Who is Patel Sanjiv?

Patel Sanjiv is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001816210.

Which companies has Patel Sanjiv reported transactions for?

Relay Therapeutics, Inc.

When was Patel Sanjiv's latest insider buy?

No open-market insider purchase is available for this period.

When was Patel Sanjiv's latest insider sale?

sale at Relay Therapeutics, Inc. on Aug 17, 2026 valued at $979,886.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.